Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
Titel:
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
Auteur:
Cree, Bruce A C Kim, Ho Jin Weinshenker, Brian G Pittock, Sean J Wingerchuk, Dean M Fujihara, Kazuo Paul, Friedemann Cutter, Gary R Marignier, Romain Green, Ari J Aktas, Orhan Hartung, Hans-Peter She, Dewei Rees, William Smith, Michael Cimbora, Daniel Katz, Eliezer Bennett, Jeffrey L